Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RVNC will rise by +6.60% over the next 2 Weeks and hit $3.89 by Wednesday, February 19, 2025. In that time frame, RVNC's share price is expected to range between $3.76 and $4.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 19, 2025 | 3.82 | 3.96 | 4.09 |
| Feb 18, 2025 | 3.82 | 3.93 | 4.08 |
| Feb 17, 2025 | 3.79 | 3.92 | 4.05 |
| Feb 14, 2025 | 3.75 | 3.89 | 4.02 |
| Feb 13, 2025 | 3.69 | 3.82 | 3.96 |
| Feb 12, 2025 | 3.72 | 3.85 | 3.98 |
| Feb 11, 2025 | 3.70 | 3.83 | 3.97 |
| Feb 10, 2025 | 3.68 | 3.81 | 3.95 |
| Feb 7, 2025 | 3.65 | 3.78 | 3.91 |
| Feb 6, 2025 | 3.58 | 3.71 | 3.84 |
RVNC shares remained flat 0 in Thursday, February 6, 2025's trading session, starting and closing at a previous close of $3.65 to move at $3.65. The stock demonstrated notable intraday movement (see RVNC's key stats for a full breakdown), fluctuating between $3.65 and $3.65, a 0 trading range. While recent weeks have seen some volatility, RVNC has managed to secure a -0.54% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 4.12M shares changing hands, 1.99M more than the previous session. This amounted to $15.05M in total market activity.
Will RVNC Continue Its Upward Trend?
According to analyst ratings and projections for RVNC, Revance Therapeutics, Inc. shares are anticipated to increase by +10.84%, potentially reaching $4.09 per share by February 19, 2025. Short-term technical indicators currently suggest a neutral sentiment for RVNC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the RVNC stock forecast, now is a good time to buy RVNC stock because its current trading price is -7.72% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on RVNC covering social and institutional perspectives.
RVNC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RVNC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 52.72% to 67.94%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 46.55%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.63%, maintains a neutral outlook for the long term. Insights into RVNC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Revance Therapeutics, Inc. Monthly Forecast 2025–2026
February 2025
According to our latest forecast models, Revance Therapeutics, Inc. (RVNC) is positioned to show a strong performance in February 2025. The price is predicted to move between $7.50 and $9.14, settling at an average of $8.39. This could translate to a +129.86% gain.
March 2025
Based on current market signals, Revance Therapeutics, Inc. is projected to trend march 2025. We forecast a trading range from $7.48 to $9.18, with a likely average price of $8.38. Investors could expect a potential return of +129.59%.
April 2025
Our predictive algorithms indicate Revance Therapeutics, Inc. stock may see a shift in April 2025. The expected range spans $7.72–$9.49, with an average target of $8.60. This represents a positive outlook and a possible gain of +135.62%.
May 2025
Analyzing established trends, Revance Therapeutics, Inc. looks set to move in May 2025. Projections place the stock between $8.15 and $10.97, averaging around $10.10. This suggests a +176.71% gain from current levels.
June 2025
Market indicators suggest Revance Therapeutics, Inc. could experience notable changes during June 2025. Prices could fluctuate within $6.67 to $10.38, with a midpoint forecast of $8.88. The stock might deliver a +143.29% gain.
July 2025
Forecasting for July 2025, models estimate that Revance Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.30 and $13.40, averaging $11.37. This signals a positive trajectory with potential returns around +211.51%.
August 2025
According to our latest forecast models, Revance Therapeutics, Inc. (RVNC) is positioned to show a strong performance in August 2025. The price is predicted to move between $6.29 and $13.29, settling at an average of $12.28. This could translate to a +236.44% gain.
September 2025
Based on current market signals, Revance Therapeutics, Inc. is projected to trend september 2025. We forecast a trading range from $5.03 to $13.19, with a likely average price of $12.40. Investors could expect a potential return of +239.73%.
October 2025
Our predictive algorithms indicate Revance Therapeutics, Inc. stock may see a shift in October 2025. The expected range spans $2.41–$13.36, with an average target of $11.60. This represents a positive outlook and a possible gain of +217.81%.
November 2025
Analyzing established trends, Revance Therapeutics, Inc. looks set to move in November 2025. Projections place the stock between $1.34 and $11.37, averaging around $9.35. This suggests a +156.16% gain from current levels.
December 2025
Market indicators suggest Revance Therapeutics, Inc. could experience notable changes during December 2025. Prices could fluctuate within $0.00 to $13.78, with a midpoint forecast of $11.31. The stock might deliver a +209.86% gain.
January 2026
Forecasting for January 2026, models estimate that Revance Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $13.50, averaging $10.73. This signals a positive trajectory with potential returns around +193.97%.
February 2026
According to our latest forecast models, Revance Therapeutics, Inc. (RVNC) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $13.53, settling at an average of $10.86. This could translate to a +197.53% gain.
RVNC's history of dividends and stock splits also plays a role in long-term investor confidence.